BioLife Plasma, a plasma donation center, opened its 200th U.S. location and first location in Pearland on March 25. The new plasma service center located at 3020 Kirby Drive is part of the ...
Plasma donation and testing company BioLife Plasma Services LP in has invested $4 million to expand its testing laboratory in Hoover, Ala., and buy equipment to recycle biohazardous plastics waste ...
Why BioLife Solutions (BLFS) is on investors’ radar BioLife Solutions (BLFS) has drawn attention after recent share price moves, with the stock up about 21% over the past month and roughly 3% in the ...
Clinical Trial Share -- BioLife products are used in over 250 commercially sponsored cell and gene therapy (CGT) clinical trials in the U.S., representing more than 70% market share, and a higher ...
BioLife Solutions focuses on cell- and gene-therapy preservation tools, used primarily by the biotech industry. The company did trim its losses, year over year, in the quarter. BioLife Solutions said ...
BioLife CEO Bill Jones calls for a new global health vocabulary, shifting from weight-loss language to biology-driven terms that support metabolic well-being, body positivity, and regenerative care.
Exclusive global supplier of non-toxic, non-flammable PCM; first to operate at -70°C, meeting critical temperature requirement of biologic materials. "We are excited to provide more value to our life ...
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the cell and gene therapy ("CGT") market, announces ...
Image source: The Motley Fool. BioLife Solutions (NASDAQ:BLFS) concluded a year of substantial revenue and margin expansion, with the business reset around core consumables and leadership in the ...
Image source: The Motley Fool. BioLife Solutions (NASDAQ:BLFS) reported 25% revenue growth and higher adjusted EBITDA, driven principally by its biopreservation media franchise and increased sales to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results